The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Arthur Gomtsyan

Global Pharmaceutical Research and Development

Neuroscience Research

Abbott Laboratories

Abbott Park

USA

[email]@abbott.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Global Pharmaceutical Research and Development, Neuroscience Research, Abbott Laboratories, Abbott Park, USA. 2004 - 2008
  • Abbott Laboratories, Neurological and Urological Diseases Research, Abbott Park, Illinois 60064, USA. 2000 - 2001

References

  1. Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management. Gomtsyan, A., Bayburt, E.K., Schmidt, R.G., Surowy, C.S., Honore, P., Marsh, K.C., Hannick, S.M., McDonald, H.A., Wetter, J.M., Sullivan, J.P., Jarvis, M.F., Faltynek, C.R., Lee, C.H. J. Med. Chem. (2008) [Pubmed]
  2. Alpha-methylation at benzylic fragment of N-aryl-N'-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model. Gomtsyan, A., Bayburt, E.K., Keddy, R., Turner, S.C., Jinkerson, T.K., Didomenico, S., Perner, R.J., Koenig, J.R., Drizin, I., McDonald, H.A., Surowy, C.S., Honore, P., Mikusa, J., Marsh, K.C., Wetter, J.M., Faltynek, C.R., Lee, C.H. Bioorg. Med. Chem. Lett. (2007) [Pubmed]
  3. Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. Gomtsyan, A., Bayburt, E.K., Schmidt, R.G., Zheng, G.Z., Perner, R.J., Didomenico, S., Koenig, J.R., Turner, S., Jinkerson, T., Drizin, I., Hannick, S.M., Macri, B.S., McDonald, H.A., Honore, P., Wismer, C.T., Marsh, K.C., Wetter, J., Stewart, K.D., Oie, T., Jarvis, M.F., Surowy, C.S., Faltynek, C.R., Lee, C.H. J. Med. Chem. (2005) [Pubmed]
  4. Nonnucleoside inhibitors of adenosine kinase. Gomtsyan, A., Lee, C.H. Curr. Pharm. Des. (2004) [Pubmed]
  5. Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors. Gomtsyan, A., Didomenico, S., Lee, C.H., Stewart, A.O., Bhagwat, S.S., Kowaluk, E.A., Jarvis, M.F. Bioorg. Med. Chem. Lett. (2004) [Pubmed]
  6. Novel sequential process from N-methoxyamides and vinyl Grignard reagents: new synthesis of beta-aminoketones. Gomtsyan, A., Koenig, R.J., Lee, C.H. J. Org. Chem. (2001) [Pubmed]
  7. Direct synthesis of beta-aminoketones from amides via novel sequential nucleophilic substitution/Michael reaction. Gomtsyan, A. Org. Lett. (2000) [Pubmed]
 
WikiGenes - Universities